Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3100)
All Articles published online
|
Aug 28, 2007 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Qiu JF, Zhang ZQ, Chen W, Wu ZY. Cystamine ameliorates liver fibrosis induced by carbon tetrachloride |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i32/4328.htm |
| Number | Citing Articles |
| 1 |
Yirong Ding, Ji Zhang, Rui Wang. Inhibition of tissue transglutaminase attenuates lipopolysaccharide-induced inflammation in glial cells through AKT/mTOR signal pathway. Biomedicine & Pharmacotherapy 2017; 89: 1310 doi: 10.1016/j.biopha.2017.03.027
|
| 2 |
Keith C. Olsen, Amali P. Epa, Ajit A. Kulkarni, R. Matthew Kottmann, Claire E. McCarthy, Gail V. Johnson, Thomas H. Thatcher, Richard P. Phipps, Patricia J. Sime. Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules. American Journal of Respiratory Cell and Molecular Biology 2014; 50(4): 737 doi: 10.1165/rcmb.2013-0092OC
|
| 3 |
Keith C. Olsen, Ramil E. Sapinoro, R. M. Kottmann, Ajit A. Kulkarni, Siiri E. Iismaa, Gail V. W. Johnson, Thomas H. Thatcher, Richard P. Phipps, Patricia J. Sime. Transglutaminase 2 and Its Role in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2011; 184(6): 699 doi: 10.1164/rccm.201101-0013OC
|
| 4 |
Ting Guo, Cindy Wantono, Yuyong Tan, Feihong Deng, Tianying Duan, Deliang Liu. Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1098129
|
| 5 |
Je Hyeong Kim. The Role of Transglutaminase-2 in Fibroproliferation after Lipopolysaccharide-induced Acute Lung Injury. Tuberculosis and Respiratory Diseases 2010; 69(5): 337 doi: 10.4046/trd.2010.69.5.337
|
| 6 |
Giuseppe D’Argenio, Daniela Caterina Amoruso, Giovanna Mazzone, Paola Vitaglione, Antonietta Romano, Maria Teresa Ribecco, Maria Rosaria D’Armiento, Ernesto Mezza, Filomena Morisco, Vincenzo Fogliano, Nicola Caporaso. Garlic extract prevents CCl4-induced liver fibrosis in rats: The role of tissue transglutaminase. Digestive and Liver Disease 2010; 42(8): 571 doi: 10.1016/j.dld.2009.11.002
|
| 7 |
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga. Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges. Biochemical Pharmacology 2023; 215: 115740 doi: 10.1016/j.bcp.2023.115740
|
| 8 |
Liming Liu, Ying Zhou, Dan Dai, Hongmei Xia, Kang Zhao, Jianjun Zhang, Samuel Martins Silvestre. Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5649575
|
| 9 |
Kempaiah Rayavara, Alexander Kurosky, Yashoda M. Hosakote. Respiratory syncytial virus infection induces the release of transglutaminase 2 from human airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2022; 322(1): L1 doi: 10.1152/ajplung.00013.2021
|
| 10 |
Hideki Tatsukawa, Kiyotaka Hitomi. Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis. Cells 2021; 10(7): 1842 doi: 10.3390/cells10071842
|
| 11 |
Ting Wang, Yan Duan, Dong Liu, Gang Li, Bin Liu. The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension. Clinical and Experimental Hypertension 2022; 44(2): 167 doi: 10.1080/10641963.2021.2013493
|
| 12 |
Doa'a G.F. Al-U'datt, Carole C. Tranchant, Muhammad Alu'datt, Sara Abusara, Ahmed Al-Dwairi, Mohammad AlQudah, Othman Al-shboul, Roddy Hiram, Yasemin Altuntas, Saied Jaradat, Karem H. Alzoubi. Inhibition of transglutaminase 2 (TG2) ameliorates ventricular fibrosis in isoproterenol-induced heart failure in rats. Life Sciences 2023; 321: 121564 doi: 10.1016/j.lfs.2023.121564
|
| 13 |
Hideki Tatsukawa, Soichi Kojima. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis. Cell Biology International 2010; 34(3): 325 doi: 10.1042/CBI20090130
|
| 14 |
Chunxiao Qi, Yaqian Li, Patrick Badger, Hongsheng Yu, Zhifeng You, Xiaojun Yan, Wei Liu, Yan Shi, Tie Xia, Jiahong Dong, Chenyu Huang, Yanan Du. Pathology-targeted cell delivery via injectable micro-scaffold capsule mediated by endogenous TGase. Biomaterials 2017; 126: 1 doi: 10.1016/j.biomaterials.2017.02.021
|
| 15 |
Soichi Kojima, Ting‐Fang Kuo, Hideki Tatsukawa. Regulation of transglutaminase‐mediated hepatic cell death in alcoholic steatohepatitis and non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 2012; 27(s2): 52 doi: 10.1111/j.1440-1746.2011.07009.x
|
| 16 |
Juanjuan Tang, Huayi Huang, Xiaofang Ji, Xunmin Zhu, Yinyan Li, Mingmin She, Suikai Yan, Mingchiu Fung, Zi Li. Involvement of IL-13 and Tissue Transglutaminase in Liver Granuloma and Fibrosis afterSchistosoma japonicumInfection. Mediators of Inflammation 2014; 2014: 1 doi: 10.1155/2014/753483
|
| 17 |
Nahla E El‐Ashmawy, Hoda A El‐Bahrawy, Maha M Shamloula, Amera O Ibrahim. Antifibrotic effect of AT‐1 blocker and statin in rats with hepatic fibrosis. Clinical and Experimental Pharmacology and Physiology 2015; 42(9): 979 doi: 10.1111/1440-1681.12446
|
| 18 |
Doa'a G.F. Al-U'datt, Carole C. Tranchant, Ahmed Al-Dwairi, Mohammad Alqudah, Othman Al-Shboul, Roddy Hiram, Bruce G. Allen, Saied Jaradat, Jenan Alqbelat, Ahmed S. Abu-zaiton. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments. Biochemical Pharmacology 2022; 201: 115104 doi: 10.1016/j.bcp.2022.115104
|
| 19 |
Deborah L Clarke, Alan M Carruthers, Tomas Mustelin, Lynne A Murray. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes. Fibrogenesis & Tissue Repair 2013; 6(1) doi: 10.1186/1755-1536-6-20
|
| 20 |
E. A. M. Verderio, A. Scarpellini, T. S. Johnson. Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids 2009; 36(4): 671 doi: 10.1007/s00726-008-0134-6
|
| 21 |
L. Elli, C.M. Bergamini, M.T. Bardella, D. Schuppan. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Digestive and Liver Disease 2009; 41(8): 541 doi: 10.1016/j.dld.2008.12.095
|
| 22 |
Nooshin Daneshpour, Martin Griffin, Russell Collighan, Yvonne Perrie. Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis. Journal of Drug Targeting 2011; 19(8): 624 doi: 10.3109/1061186X.2010.531731
|